Transcription of NEW ZEALAND DATA SHEET - Medsafe
{{id}} {{{paragraph}}}
Example: dental hygienist
NEW ZEALAND DATA SHEET - Medsafe
Version: pfdsutec10818 Supersedes: pfdsutec10617 Page 1 of 31 NEW ZEALAND data SH EE T 1. PRODUCT NAME SUTENT (sunitinib mg capsules) SUTENT (sunitinib 25 mg capsules) SUTENT (sunitinib mg capsules) SUTENT (sunitinib 50 mg capsules) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION The active ingredient of SUTENT is sunitinib malate. SUTENT capsules contain sunitinib malate equivalent to mg, 25 mg, mg or 50 mg sunitinib. For the full list of excipients, see section 3. PHARMACEUTICAL FORM SUTENT is supplied as a hard gelatin capsule for oral administration. mg strength: Hard gelatin capsule with Swedish Orange cap and Swedish Orange body, printed with white ink Pfizer on the cap, STN on the body. 25 mg strength: Hard gelatin capsule with caramel cap and Swedish Orange body, printed with white ink Pfizer on the cap, STN 25mg on the body.
NEW ZEALAND DATA SHEET 1. PRODUCT NAME SUTENT (sunitinib 12.5mg capsules) SUTENT (sunitinib 25 mg capsules) SUTENT (sunitinib 37.5 mg capsules)
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: